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Significance of the study 
Our aim was to improve the 50% detection rate of ultrasonographic fetal biometry in the diagnosis 
of intra-uterine growth restriction (IUGR). This study shows that the correlation between placental 
volume and birthweight is strong, and that the umbilical artery lumen area is decreased in IUGR. 
Among the maternal blood parameters only the platetlet count correlates with clinical fndings. The 
evaluation of these data can make the diagnosis more accurate. 
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Abstract  
Objecitve: To investigate the placental and umbilical cord histopathology in IUGR, and their relation 
to second trimester maternal haematological parameters.  Materials and Methods: Patients were 
selected for IUGR group based on estimated fetal weight below the 10th percentile. Patients were 
recruited in the control group randomly. Patients were followed up with ultrasound, and blood 
samples taken between the 20-24th gestational weeks. After delivery and formalin fixation, weight 
and volume of the placenta were recorded and histologic samples were processed.  Results: Maternal 
platelet count strongly correlates with placental weight (r = 0.766). On the other hand, neonatal 
weight correlates with placental volume (r = 0.572) rather than with placental weight (r = 0.469). 
Umbilical arterial lumen crossectional area correlates with birthweight (r = 0.338).  Conclusions: 
Maternal haematological parameters do not seem to affect neonatal outcome. Our main findings are 
the correlation of maternal platelet count with placental weight, that the correlation of placental 
volume with birthweight is stronger than the correlation of placental weight with birthweight, and 
the correlation of umbilical artery lumen cross sectional area with neonatal weight. Mild 
histopathologic alterations might occur in normal pregnancies, however sufficient fetal nutrition can 
be maintained. This compensatory function of the placenta seems to be insufficient when two or more 
pathologies are present, which is characteristic for IUGR. 
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Introduction 
Intrauterine growth restriction (IUGR) increases perinatal mortality by10-25% and morbidity 
by 50-75% and predisposes the newborn to metabolic syndrome, diabetes mellitus, stroke and heart 
disease. The placental microvasculature is essential for the sufficient transfer of gases, nutrients and 
metabolites between the mother and the fetus [1]. The size, weight and shape of the placenta may 
vary within wide extreme values, and placental size is related to its ability to transfer nutrients [1-2]. 
The relationship between placental morphometry and adverse pregnancy outcome, including IUGR 
is known [3]. Small placental size, decreased placental surface area [4] and small placental volume 
[5] have been associated with increased risk of IUGR. Placental weight increases linearly as gestation 
progresses and its capacity to transfer metabolites increases and compensates for its slow growth 
related to fetal development. Weight and volume of placentas associated with IUGR are lower than 
that of their normal-weight counterparts [6]. Placental co-efficients (placental weight/fetal weight 
ratio) between 0.10 and 0.18 are considered normal. The literature is not consistent regarding overall 
placental volume. In some cases as the functioning placental tissue tries to compensate for the 
reduced circulation, the placental weight might not be reduced in IUGR [7]. Placentas of infants with 
IUGR are characterized by smaller diameters, increased placental coefficient and decreased placental 
weight and volume as compared to that of normal-weight infants [8]. It is not clear yet how placental 
weight and volume are related. Sonographically placental volume can be used to detect placental 
growth restriction that precedes fetal IUGR by several weeks [9]. There are placental vascular 
pathologies (calcification, reduced capillarization in the terminal villi, reduced cytotrophoblast 
proliferation, chronic villitis, infarcts, perivillous fibrin deposition, etc) that are associated with 
growth restriciton, the presence of which does not explain how low birthweight and mild forms are 
present in normal pregnancies too [10]. 
Placental function can be assessed in vivo by utero-placental Doppler flow velocimetry, and 
fetal growth can be assessed by serial ultrasonic biometry. The flow velocity waveform in the 
umbilical artery normally shows low resistance in the last trimester of pregnancy, and this is thought 
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to reflect the development of the villous vascular tree [11]. High resistance in the umbilical artery is 
widely used as an indicator of placental dysfunction, where the elevation of resistance correlates with 
the maldevelopment of the tertiary villi [1]. Low for gestational age fetuses show abnormal blood 
flow velocity wave forms in the umbilical and uterine artery with reduced, absent or reverse diastolic 
flow and abnormally reduced blood flow per unit of fetal weight. IUGR remains a diagnostic 
challenge, as ultrasound provides a detection rate of only 50%. The explanation for low detection 
rate might be that biometry and flowmetry does not give direct information about the ratio of 
functional/pathological placental tissue, it provides information only indirectly [12]. 
Maternal hemoglobin level (Hgb) might be another marker in IUGR screening. High placental 
co-efficient with low maternal Hgb suggests differences of placental growth related to fetal growth 
[13]. Although severe anemia is associated with IUGR, maternal iron status cannot be assessed 
simply from Hgb concentration because plasma volume is increased in pregnancy and Hgb 
concentration decreases accordingly. The failure of the plasma volume to expand itself might cause 
growth restriction too [14]. Mean corpuscular volume (MCV) of red blood cells does not change 
substantially during pregnancy, therefore it might be a better choice for predicting adverse fetal 
outcome [14]. Yet there is no sufficient evidence of a relationship between placental ratio, Hgb 
concentration or MCV [15]. Other studies report that the decrease in haemoglobin concentration in 
pregnancy is related to birth weight; failure of the Hgb concentration to fall below 105 g/l indicates 
an increased risk of low birth weight and preterm delivery [16]. High blood viscosity, elevated 
platelet count (PLT) and spontaneous platelet aggregation can be a risk factor for vascular occlusions 
and a novel risk factor for adverse pregnancy outcomes such as pre-eclampsia and IUGR too [17]. 
Most studies on the inter-relationships between antenatal uteroplacental Doppler blood flow 
velocimetry and the postnatal findings have focused on the microscopic and ultrastructural 
characteristics of the placenta [18] or the relationship between fetal weight and the gross morphology 
of the placenta [19]. 
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The objective of this study was to evaluate pathological changes of the placenta and umbilical 
cord in connection with IUGR pregnancies and to investigate wether birthweight or placental changes 
are influenced by maternal hematologic blood parameters.  
Materials and Methods 
Study Design 
Pregnant subjects were recruited in a prospective case-control study between January 2014 
and December 2016 in the Department of Obstetrics and Gynecology, University of Szeged, Szeged, 
Hungary. Each subject signed informed consent in accordance with the Declaration of Helsinki and 
were followed up until delivery. Clinical data were collected from the medical anamnesis, blood 
parameters were taken in the second trimester, between 24th-30th weeks of gestation. Subjects were 
classified into the IUGR group if the estimated fetal weight on the 20th week of gestation was below 
the 10th percentile as per race, gender and gestational age, and recruited into the control group 
randomly. For birth weight precentile we used the sex-specific percentile scale of the International 
Society of Ultrasound in Obstetrics and Gynecology [20]. Patients with twin pregnancies, preterm 
births, genetic malformations, chromosomal or developmental disorders, hypertension (<140/80 
Hgmm), diabetes (fasting plasma glucose <6.9 mmol/l measured at 24th week of gestation), alcohol, 
nicotine or drug abuse were excluded from the study. Patients involved in the study did not have 
immunological, cardiovascular, gastrointestinal or pulmonary disease. 
Data Collection 
Every ultrasound examination was performed by the same person to avoid interorbserver 
variability. All patients were scanned in a semirecumbent position. The factorial default setting 
"Obstetrics/2-3 trimester" was used in 2-D mode on a GE Voluson 730 machine. Gestational age was 
determined based on the first day of the last menstrual period and on ultrasound biometry (crown 
rump length and biparietal diameter) between 9-11th weeks of pregnancy. In the 20-24th week fetal 
biometry was used to assess estimated fetal weight by the formula B of Hadlock [21]. A conventional 
color Doppler study of the umbilical arteries were also performed and the S/D ratio was read from 
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report display of ultrasound. After delivery the weight of the neonate and placental volume were 
measured. For volume measurements we used the water replacement technique. 
Umbilical Cord and Placental Sample Processing 
After 3-7 days of formalin fixation, placental weight and volume were measured and gross 
examination of the placenta and the umbilical cord was executed by an expert pathologist according 
to the Guideline of Royal College of Pathologists, 2011 [22]. After measuring the diameters, the 
placenta was cut along the longest diameter in 1 cm thick strips using a brain knife and the thickness 
of the tissue was measured at the umbilical cord insertion. Umbilical cord samples were taken from 
the placental end and cut into transversal slices of four millimetres, perpendicular to the umbilical 
cord. The slices were dehydrated in graded ethanol series, cleaned in xylene and embedded in 
paraffin. Paraffin samples were sectioned at 4 micrometers. After Haematoxylin/Eosin (HE) staining 
histologic samples were analyzed via Axio Vision SE64 Rel. 4.9.1. microscope.The following 
parameters of the umbilical cord were measured in digitised HE stained sections; umbilical cord 
longest cross sectional diameter, vessel lumen area and vessel wall thickness. Because of the 
umbilical cord coiling, the surface of the vessels were not mathematically-perfect cross sections, and 
we standardized our measurements to the highest point of torsion, lowest point of torsion and an extra 
measurement at 3, 6 or 9’O clock position dependending on the first two points. Placental histological 
samples (3mm x 10mm x 20mm) were taken from the umbilical cord insertion, the edge of the 
placenta, the fetal and maternal side of the placenta and from the pathological alteration(s), if there 
were any. 
Statistical Analysis 
For normally distributed maternal and neonatal characteristics and outcomes of the umbilical 
cord and placenta we used t-test, and Analysis of Variance (ANOVA) was applied to assess 
differences in vessel wall thickness depending on different lumen shapes in arteries. The Kruskall-
Wallis test was applied to skewed variables with Bonferroni correction. Differences were considered 
statistically significant at p < 0.05. After a mutiparametric correlation analysis with post-hoc 
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adjustment for multiple comparisons, linear regression analysis was applied to investigate the 
relationships among maternal blood parameters and clinical outcome. Correlation was evaluated as 
“strong” if the value of r was above 0.5, “moderate” between 0.3 and 0.5 and “weak” under 0.3. All 
analyses were performed via Prism 6 (Graph Pad Software Inc. San Diego USA). 
Results 
54 patients (46 controls, 8 IUGR) were recruited. Clinical data and maternal blood parameters 
are shown in Table 1. Values of mean corpuscular volume of red blood cells (r = 0.0487), red blood 
cell count (r = 0.0147), hemoglobin (r = 0.1098), hematocrit (r = 0.0016), platelet count (r = 0.0009), 
prothrombin time (r = 0.0048), INR (r = 0.0148) or activated partial thromboplastin time (r = 0.0240) 
did not correlate with neonatal weight. Platelet count showed strong correlation with placental weight 
(r = 0.7660). Gross pathological examination revealed that placental volume measured right after 
delivery shows the strongest correlation with birthweight rather than with placental weight or with 
volume after formalin fixation (Fig. 1). The results of histological examination are shown in Tables 
2 and 3. The prevalence of obliterated, star-shaped lumen in one or both arteries did not differ in the 
IUGR or control cases (Fig. 2), but the lumen-cross sectional area shows mild correlation with 
birthweight (r = 0.336). We found nonconversion of maternal arteries in the placenta that is similar 
to that of the uterine arteries seen via ultrasound as end diastolic stop of blood flow (notch). The five 
such cases did not coincide with notch in uterine arteries in our ultrasonographic data on uterine 
arteries. 
 
Discussion 
This study shows that the correlation between placental volume and birthweight is stronger 
than the correlation between placental weight and birthweight. The umbilical artery lumen area is 
significantly decreased in IUGR pregnancies. Among the maternal peripheral venous blood 
parameters only the platetlet count correlates with the clinical fndings. Other blood parameters that 
could alter maternal blood viscosity seem to have no effect on fetal weight. Blood samples were taken 
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between the 20th-24th weeks of gestation, right after when the placental vascular tree had developed 
and the ultrasonographically measurable sings of placental malperfusions were detectable. 
The results draw attention to antenatally measurable possible predictor of intrauterine growth 
restriction, the placental volume, the shortest diameter of placenta and the lumen area of umbilical 
arteries in IUGR. The strength of this study is that each kind of measurement was performed blindly 
and by only one researcher. A limitation of this study is the small number of cases. In our clinic the 
annual birthrate is about 2300, and IUGR pregnancies with known etiologic backgrounds (other than 
placental insufficiency) were excluded. 
Elevated numbers of maternal mononuclear cells and increased levels of cytokines have been 
reported  in preeclampsia, and also the cytokine levels produced is higher. The high proinflammatory 
cytokine concentration may cause endothelial dysfunction and thus vasoconstrictions [23]. We 
excluded pregnant patients with preeclampsia or hypertension, and in connection with intrauterine 
growth restriction we did not observe the same correlation. Based on the data collected from maternal 
hemathologic parameters in our study, we would not suggest them for further studies of predictors of 
low birthweight. Only the platelet count shows correlation with clinical findings and it does not affect 
birthweight. In contrast with the cellular compounds of the maternal blood, cytokines and tumor 
necrosis factor alpha (TNF-α) levels might be worth measuring in IUGR pregnancies [23-24]. 
Our data shows that placental volume measured after delivery has stronger correlation with 
birthweight than does placental weight with birthweight. Although these parameters differ 
significantly between the two groups, they do not reflect functional variability within the tissue. In a 
large placental disc with confluent infarctions, calcification would still be in the upper range of 
weight and volume but would belong to a growth-restricted fetus. We recommend the development 
of a reliable in-utero method to estimate functional placental volume that refines the estimated fetal 
weight. We also suggest establishments of percentile curves of trimmed placental weights to be used 
for predicting growth restriction. The placental volume can be estimated by ultrasound more 
accurately than by placental weight [13]. Placental volume and shape also can be determined via 
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medical resonance imaging (MRI). MRI gives additive information about the textural features and 
shape of the placenta. Placentas in IUGR pregnancies tend to be more oval and thicker than placentas 
of healthy fetuses which are more circular [25]. Our morphologic measurements support these 
observations. Some studies managed to establish a percentile curve placental volume. After some 
routinely performable measurements, new diagnostic reference values could be used [26]. 3-
dimensional placental measurements in the first trimester showed moderate correlation with fetal 
weight. Measurements in the second trimester performed along the fetal side of the placenta have 
better predictive values (up to 45%) and can be used for screening patients at high risk [27].  
Our results confirm that mild histopathologic alterations might be present in normal 
pregnancies, until there is enough functional placental tissue, sufficient fetal nutrition can be 
maintained [13]. This compensatory residual of the placenta becomes insufficient when two or more 
pathologies are present, which is characteristic for IUGR. We have found nonconversion of the 
arteries in the maternal side of the placenta. The five cases did not coincide with notch in uterine 
arteries. With a mathematical model it has been demonstrated that the vessel wall shear stress and 
blood velocity jets are bigger in uterine arteries in IUGR and also vortices occur more often in the 
intervillous space [28]. This condition of increased turbulence with increased platelet count promotes 
the formation of microthrombus that explains the intervillous deposition of fibrin and increased 
placental weight related to birthweight in IUGR pregnancies. Umbilical vessels are coiling together 
along the cord and their cross section perpendicularly to the longitudinal axis of the cords will rarely 
be a true mathematical cross-section. This artefact causes torsion, oval or bean shaped lumen and 
variability in measurements of vessel wall thickness. In cases of strict arterial constriction, a star 
shaped lumen can be seen. To overcome this adversity we standardized our method based on this 
torsion and performed an additional measurement semi-independently. This method is reproducible 
in ultrasonography. Only the lumen cross-sectional area of the umbilical arteries differed between 
the IUGR and control group. Our finding of non-significantly decreased arterial vessel wall thickness 
conforms to published literature [29-30].  
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Conclusion 
The novelty of our study is the correlation of maternal platelet count with placental weight, 
the stronger correlation of placental volume with birthweight than the correlation of placental weight 
with birthweight, and the correlation of umbilical artery lumen cross sectional area and neonatal 
weight. Larger studies are needed to ascertain whether these alterations in umbilical arteries are part 
of a fetal response to under-nutrition or the etiology of part of IUGR. Further studies are also needed 
to establish a diagnostic method involving similar findings to increase the accuracy of predicting fetal 
outcome. 
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Table 1: Clinical data of the mothers and newborns 
 
IUGR (n = 8) Control (n = 46) 
p mean ±SD mean ±SD 
 
MCV (fL) 
 
84.48 
 
0.96 
 
88.25 
 
1.26 
 
ns 
RBC (T/L) 4.07 0.03 4.03 0.10 ns 
Hgb (g/L) 123.80 4.48 121.50 2.31 ns 
Htk (L/L) 0.35 0.01 0.36 0.01 ns 
PLT (Giga/L) 235.50 24.73 197.80 11.81 ns 
MPV (fL) 10.65 0.66 12.01 0.32 ns 
Prothrombin time (sec) 12.80 0.10 12.93 0.13 ns 
INR 0.97 0.01 0.98 0.01 ns 
APTT (sec) 33.93 0.26 32.03 0.47 ns 
umbilical artery S/D 3.39 0.38 2.22 0.11 0.0006 
maternal age (year) 29.75 1.11 25.72 3.64 ns 
maternal BMI (kg/m2) 28.48 2.35 22.46 1.83 ns 
parity 0.85 0.16 1.48 0.34 ns 
Birthweight (g)  2110.00 194.0  3367.73 435.04 0.0023 
Gestational age (weeks) 37.29 1.10  38.58 1.58 ns 
1' Apgar score 7.71 1.14 8.38 1.85 0.036 
5' Apgar score 8.86 1.46 9.46 1.13 ns 
10' Apgar score 9.57 1.13 9.92 0.28 ns 
male (%) 50.00 - 45.94 - ns 
female (%) 50.00 - 54.05 - ns 
 
Maternal peripheral venous blood parameters: MCV = mean corpuscular volume of red blood cell, 
RBC = red blood cell count, Hgb = haemoglobin, Htk = hematocrit, PLT = platelet count, MPV = 
mean platelet volume, INR = intrenational normalized ratio, APTT = activated partial 
thromboplastin time, BMI = body mass index. Arteria umbilicalis S/D = the systolic and diastolic 
blood flow velocity ratio, ns = not significant. 
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Table 2: Placental histopathologic alterations 
 
IUGR  (n = 8) Control    (n = 46) 
n % n % 
 
Focal calcification 2 25.00 5 10.87 
Villous hypovascularization 4 50.00 2 4.35 
Villous hypoplasia 4 50.00 7 15.22 
Intervillous fibrin depositition 3 37.50 5 10.87 
Syncytial nod 3 37.50 1 2.17 
Amnion nodosum 0 0.00 1 2.17 
Villitis 0 0.00 1 2.17 
Haematoma 0 0.00 2 4.35 
Nonconversion of maternal vessels 
 
2 
 
25.00 
 
3 
 
6.52 
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Table 3:Umbilical cord and placental pathology 
 
IUGR (n = 8) Control (n = 46) 
p Mean ±SD Mean ±SD 
 
Vena umbilicalis vessel wall 
thickness (µm) 663.8 41.6 605.4 20.6 ns 
Vena umbilicalis lumen area (µm2) 1563000.0 1054000.0 1803000.0 514365.0 ns 
Arteria umbilicalis vessel wall 
thickness (µm) 636.4 41.0 678.2 15.0 ns 
Arteria umbilicalis lumen area  
(µm2) 146825.0 18369.0 526659.0 77690.0 0.0296 
Ratio of star shaped arteries 0.71 0.29 0.89 0.13 ns 
UCI 1.05 0.27 1.52 0.44 ns 
Umbilical cord diameter (mm) 93.20 8.34 116.10 6.24 ns 
Number of placental pahologies 
present 2.13 0.30 0.70 0.11 < 0.0001 
Native placental volume (ml) 315.30 23.44 492.50 17.95 < 0.0001 
Placental volume after formalin 
fixation (ml) 368.80 23.15 461.50 15.01 0.0018 
Placental weight after formalin 
fixation (g) 401.80 18.33 468.90 15.49 0.0226 
Longest placental diameter (cm) 15.50 1.15 15.86 0.20 ns 
Shortest placental dimaeter (cm) 13.11 0.46 14.39 0.29 0.0196 
Placental thickness (cm) 2.58 0.14 2.71 0.08 ns 
Placental co-efficient 
 
1.19 
 
 
0.01 
 
0.14 
 
0.01 
 
< 0.0001 
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Figure Legend 
Fig. 1. Placental morphometry; placental volume measured after delivery (A) shows the strongest 
correlation with birthweight not the placental volume (B) or weight (C) after formalin fixation. 
Fig. 2. Placental and umbilical cord histopathology; normal placental tissue (A) with vascularized 
villi and intrauterine growth-restricted placental tissue (B) with hypovascularization and intervillous 
fibrin deposition. (HE, 200x) 
Different coiling patterns (C) that can distort vessel cross section and an obliterated, star shaped 
umbilical artery lumen (D) with perivascular haematoma and asymmetrical vessel wall. (HE, 400x) 
Perivascular haematoma is the result of intrapartum pulling of the umbilical cord. 
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Fig. 1. 
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Fig. 2. 
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